The Global Tech Platform Aiming to Revamp Cancer Care

Driver, developed by a Harvard-trained oncologist, aims to connect cancer patients with tailored treatments globally. The platform addresses market failures in accessing treatments and clinical trials, exacerbated by a shortage of oncologists. Driver acts as a technological intermediary between patients and doctors, enhancing treatment access. The company positions itself as a tech firm, not a healthcare entity, focusing on patient-centric solutions and avoiding reliance on big pharma for funding.

What is the primary goal of the Driver platform?

• To focus solely on the Chinese market

• To replace doctors in cancer treatment

• To connect patients with personalized treatments globally

• To develop new cancer treatments

What problem does the Driver platform aim to solve?

• Shortage of cancer research

• High cost of cancer treatments

• Lack of cancer treatments

• Market failure in accessing treatments

How does Driver position itself in the healthcare ecosystem?

• As a pharmaceutical company

• As a replacement for doctors

• As a new cancer treatment

• As a middleman between patients and doctors

What is a significant issue in the U.S. cancer treatment system?

• Lack of insurance coverage

• Overabundance of oncologists

• Patients not receiving standard care

• High cost of treatments

What percentage of Americans have access to clinical trials?

• More than 80%

• Less than 3%

• Around 25%

• About 50%

What is a major challenge in the global oncology field?

• Excessive number of oncologists

• Overfunding of cancer research

• Shortage of oncologists

• Lack of cancer patients

How does Driver view its identity as a company?

• As a pharmaceutical company

• As a healthcare company

• As a technology company

• As a health tech company